1, Pfizer's revenue in the US market in 20 18 was $25.32 billion, which was 2.75% lower than that in 20 17. Pfizer has the highest revenue in the US market, accounting for 47.26438+0% of the total sales in fiscal year 20 18.
2. Johnson & Johnson's revenue in the US market was $23.28 billion, an increase of 8.43% compared with 20 17. The sales of American companies were $46,543.80 billion in 2065,438+08, $39.9 billion in 2065,438+07 and $37.8 billion in 2065,438+06.
3. Roche Holdings' revenue from the US market in fiscal year 20 18 was $22.76 billion, an increase of 13.35% compared with fiscal year 20 17. In the United States, the sales of products led by Ocrevus, Perjeta and Lucentis increased rapidly.
4.20 18 fiscal year, Abway's revenue in the United States was $2152 billion, an increase of 17.9% compared with fiscal year 20 17. The products sold by the company in the world have been influenced by the introduction of several direct biosimilars, which are much cheaper than AbbVie, resulting in a decline in its sales in Europe and other international markets.
5. In 20 17 years, Amgen's business income in the United States increased by 1.27%, reaching182.8 billion US dollars, and global product sales increased by 8%. Recently, new products including Repatha, Prolia, KYPROLIS and XGEVA have achieved double-digit growth. 6. The revenue of Novartis in fiscal year 20 18 was175.6 billion USD, which was 3.69% higher than that in fiscal year 20 17. Novartis has decided to give up Alcon's eye care department and American generic drug business and focus on new high-tech drugs.
7. Merck's revenue in fiscal year 20 18 was166 billion USD, an increase of 4.76% over fiscal year 20 17. Merck's total revenue is expected to increase by 5.68%, reaching $44.7 billion in fiscal year 20021. In 20021year, Merck said that according to non-GAAP, earnings per share ranged from $4.57 to $4.72, and global sales ranged from $43.2 billion to $44.7 billion.
8. Gilead Science Company Gilead Science Company is an American biopharmaceutical company dedicated to the development and commercialization of innovative drugs. Gilead's main areas of concern include AIDS, liver disease, hematology/oncology and inflammation/respiratory diseases. Gilead's revenue in fiscal year 20 18 was162 billion USD.
In 9.20 18, the registered drug income of Sanofi Co., Ltd. in the US market was $65,438 +03. 15, which was 2.66% lower than that in 20 17.
10, Bristol-Myers Squibb Company 20 18, and Bristol-Myers Squibb Company's revenue in the US market was1258 million US dollars, an increase of 1 1% over the fiscal year 20 17. Bristol-Myers Squibb's revenue in the United States in the fourth quarter increased by 16% compared with the same period of last year, reaching $3.3 billion.
Japan's pharmaceutical industry is quite developed, and the Japanese's rigorous attitude towards work is particularly suitable for the pharmaceutical industry. In the list of top 50 pharmaceutical companies in the world or 100, Japan usually occupies many seats, second only to the United States. Among them, Juniors * * *, Astaire, Cai Wei, Takeda and Otsuka are the five largest pharmaceutical companies in Japan, and they are also among the top in the world.
r
1. Sun Pharmaceutical, 2. Rubin LupinLtd, 3 years old. Dr. Reddy's lab.